Anthony McGrogan
Vice President and General Manager, Single Port PlatformIntuitive Surgical
Medical DevicesView Profile →Chief Science, Technology and Medical Affairs Officer · Zimmer Biomet Holdings
Jonathan M. Vigdorchik is chief science, technology and medical affairs officer of Zimmer Biomet Holdings. An orthopedic surgeon, researcher and entrepreneur, he has held clinical and academic leadership roles at Hospital for Special Surgery and NYU Langone.
Last reviewed: Nov 4, 2026
Chief Science, Technology and Medical Affairs Officer
Zimmer Biomet Holdings
Last Reviewed: November 4, 2026
Jonathan M. Vigdorchik is chief science, technology and medical affairs officer of Zimmer Biomet Holdings. An orthopedic surgeon, researcher and entrepreneur, he has held clinical and academic leadership roles at Hospital for Special Surgery and NYU Langone.
Vigdorchik completed his medical degree at the University of Missouri–Columbia in 2007. He subsequently completed orthopedic surgery residency at Detroit Medical Center/Providence Hospital in 2012 and an adult reconstruction and joint replacement fellowship at Hospital for Special Surgery in 2013. That year, he also undertook international traveling fellowship training in hip preservation.
His clinical and research career has focused on hip and knee replacement, hip preservation and surgical technology. At NYU Langone Orthopedic Hospital, he served as fellowship director in Adult Reconstruction and co-director of its Robotics and Computer-assisted Orthopaedic Surgery Program.
At HSS, Vigdorchik served as division chief for national and international reputation and academic promotion within Adult Reconstruction and Joint Replacement and as director of Bone Implant Longevity Research at the Griffin Research Accelerator. He is also an associate professor of orthopedic surgery at Weill Cornell Medical College. His professional work includes peer-reviewed research, patents and founding four start-ups.
Vigdorchik became Zimmer Biomet’s chief medical technology advisor for Adult Reconstruction and Hip Implants in August 2025. He moved into the chief science, technology and medical affairs officer position on April 14, 2026, reporting to Ivan Tornos. He oversees the global technology portfolio, medical education strategy and Global Advisory Board, covering robotics, software and data, connected technologies and implants.
Vigdorchik earned an honors BA in finance and economics from Washington University in St. Louis and his medical degree from the University of Missouri–Columbia. He completed orthopedic residency and adult reconstruction, joint replacement and hip preservation fellowship training.